SEC Form SC 13G/A filed by Alignment Healthcare Inc. (Amendment)

2/13/23 4:22:12 PM ET

$ALHC

Medical Specialities

Health Care

Get the next $ALHC alert in real time by email

SC 13G/A 1 eh230329299_13ga1-alignment.htm AMENDMENT NO. 1

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Alignment Healthcare, Inc.

(Name of Issuer)

Class A common stock, par value $0.001 per share

(Title of Class of Securities)

01625V104

(CUSIP Number)

December 31, 2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

	☐	Rule 13d-1(b)
	☐	Rule 13d-1(c)
	☒	Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 01625V104

SCHEDULE 13G

Page 2 of 22

1	NAME OF REPORTING PERSON General Atlantic, L.P.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON PN

CUSIP No. 01625V104

SCHEDULE 13G

Page 3 of 22

1	NAME OF REPORTING PERSON General Atlantic Partners 95, L.P.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON PN

CUSIP No. 01625V104

SCHEDULE 13G

Page 4 of 22

1	NAME OF REPORTING PERSON GAPCO GmbH & Co. KG
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Germany

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON PN

CUSIP No. 01625V104

SCHEDULE 13G

Page 5 of 22

1	NAME OF REPORTING PERSON GAP Coinvestments III, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON OO

CUSIP No. 01625V104

SCHEDULE 13G

Page 6 of 22

1	NAME OF REPORTING PERSON GAP Coinvestments IV, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON OO

CUSIP No. 01625V104

SCHEDULE 13G

Page 7 of 22

1	NAME OF REPORTING PERSON GAP Coinvestments V, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON OO

CUSIP No. 01625V104

SCHEDULE 13G

Page 8 of 22

1	NAME OF REPORTING PERSON GAP Coinvestments CDA, L.P.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON PN

CUSIP No. 01625V104

SCHEDULE 13G

Page 9 of 22

1	NAME OF REPORTING PERSON General Atlantic (SPV) GP, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON OO

CUSIP No. 01625V104

SCHEDULE 13G

Page 10 of 22

1	NAME OF REPORTING PERSON GAPCO Management GmbH
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Germany

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON CO

CUSIP No. 01625V104

SCHEDULE 13G

Page 11 of 22

1	NAME OF REPORTING PERSON General Atlantic GenPar, L.P.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON PN

CUSIP No. 01625V104

SCHEDULE 13G

Page 12 of 22

1	NAME OF REPORTING PERSON General Atlantic (ALN HLTH), L.P.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☒
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

60,993,323

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

60,993,323

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 60,993,323
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 32.6%
12	TYPE OF REPORTING PERSON PN

CUSIP No. 01625V104

SCHEDULE 13G

Page 13 of 22

Item 1.	(a)	NAME OF ISSUER

	Alignment Healthcare, Inc. (the “Company”).

	(b)	ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES

	1100 W. Town and Country Road, Suite 1600, Orange, CA 92868

Item 2.	(a)	NAMES OF PERSONS FILING

	This Statement is being filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

	(i)	General Atlantic, L.P. (“GA LP”)

	(ii)	General Atlantic Partners 95, L.P. (“GAP 95”);

	(iii)	GAPCO GmbH & Co. KG (“GAPCO GmbH”);

	(iv)	GAP Coinvestments III, LLC (“GAPCO III”);

	(v)	GAP Coinvestments IV, LLC (“GAPCO IV”);

	(vi)	GAP Coinvestments V, LLC (“GAPCO V”);

	(vii)	GAP Coinvestments CDA, L.P. (“GAPCO CDA”);

	(viii)	General Atlantic (SPV) GP, LLC (“GA SPV”);

	(ix)	GAPCO Management GmbH (“GAPCO Management”)

	(x)	General Atlantic GenPar, L.P. (“GA GenPar”)

	(xi)	General Atlantic (ALN HLTH), L.P. (“GA ALN”);

	GA 95, GAPCO GmbH, GAPCO III, GAPCO IV, GAPCO V, and GAPCO CDA are collectively referred to as the “GA Funds.”

CUSIP No. 01625V104

SCHEDULE 13G

Page 14 of 22

	(b)	ADDRESS OR PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE

	The address of GA LP, GAP 95, GAPCO III, GAPCO IV, GAPCO V, GAPCO CDA, GA SPV, GA GenPar, and GA ALN is c/o General Atlantic Service Company, L.P., 55 East 52nd Street, 33rd Floor, New York, NY 10055. The address of GAPCO GmbH and GAPCO Management is c/o General Atlantic GmbH, Luitpoldblock, Amiraplatz 3, 80333 München, Germany.

	(c)	CITIZENSHIP

	(i)	GA LP - Delaware

	(ii)	GAP 95 - Delaware

	(iii)	GAPCO GmbH - Germany

	(iv)	GAPCO III - Delaware

	(v)	GAPCO IV - Delaware

	(vi)	GAPCO V - Delaware

	(vii)	GAPCO CDA - Delaware

	(viii)	GA SPV - Delaware

	(ix)	GAPCO Management - Germany

	(x)	GA GenPar - Delaware

	(xi)	GA ALN - Delaware

	(d)	TITLE OF CLASS OF SECURITIES

	Common stock, par value $0.001 per share (the “common stock”).

	(e)	CUSIP NUMBER

	01625V104

CUSIP No. 01625V104

SCHEDULE 13G

Page 15 of 22

Item 3.	IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS:

	Not applicable.

Item 4.	OWNERSHIP

	As of December 31, 2022, the Reporting Persons owned the following number of the Company’s common stock:

	(i)	GA LP owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock

	(ii)	GAP 95 owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock

	(iii)	GAPCO GmbH owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock

	(iv)	GAPCO III owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock

	(v)	GAPCO IV owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock

	(vi)	GAPCO V owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock

	(vii)	GAPCO CDA owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock

	(viii)	GA SPV owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock

	(ix)	GAPCO Management owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock

	(x)	GA GenPar owned of record no shares of common stock or 0.0% of the issued and outstanding shares of common stock

	(xi)	GA ALN owned of record 60,993,323 shares of common stock or 32.6% of the issued and outstanding shares of common stock

CUSIP No. 01625V104

SCHEDULE 13G

Page 16 of 22

	The GA Funds share beneficial ownership of the shares of common stock held by GA ALN. The general partner of GA ALN is GA SPV. The general partner of GAP 95 is GA GenPar and GA GenPar is ultimately controlled by GA LP. The general partner of GAPCO GmbH is GAPCO Management. GA LP, which is controlled by the Management Committee of GASC MGP, LLC (the “Management Committee”), is the managing member of GAPCO III, GAPCO IV and GAPCO V, the general partner of GAPCO CDA and GA GenPar, and the sole member of GA SPV. There are nine members of the Management Committee. By virtue of the foregoing, the Reporting Persons may be deemed to share voting power and the power to direct the disposition of the shares that each owns of record. Each of the members of the Management Committee disclaims ownership of the shares of common stock reported herein except to the extent that he has a pecuniary interest therein. The name, the address and the citizenship of each of the members of the Management Committee as of the date hereof is attached hereto as Schedule A and is hereby incorporated by reference.

	Amount Beneficially Owned:
	By virtue of the relationship described above, each of the Reporting Persons may be deemed to beneficially own 60,993,323 shares of common stock.

	Percentage Owned:
	All calculations of percentage ownership herein are based on an aggregate of 187,260,981 shares of common stock reported by the Company to be outstanding, as reflected in the Company's Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on November 3, 2022.

	Number of Shares as to Which Such Person Has Sole/Shared Power to Vote or to Direct the Vote and Sole/Shared Power to Dispose or to Direct the Disposition of:
	(i)	Each of the Reporting Persons may be deemed to have the sole power to direct the voting and dispositions of the shares of common stock as indicated on such Reporting Person’s cover page included herein.

	(ii)	Each of the Reporting Persons may be deemed to share the power to direct the voting and dispositions of the 60,993,323 shares of common stock that may be deemed to be owned beneficially by each of them.

Item 5.	OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

	Not applicable.

CUSIP No. 01625V104

SCHEDULE 13G

Page 17 of 22

Item 6.	OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

	Not applicable.

Item 7.	IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

	Not applicable.

Item 8.	IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

	See Item 2, which states the identity of the members of the group filing this Schedule 13G.

Item 9.	NOTICE OF DISSOLUTION OF GROUP

	Not applicable.

Item 10.	CERTIFICATION

	Not applicable.

CUSIP No. 01625V104

SCHEDULE 13G

Page 18 of 22

Exhibit Index

Exhibit 1

Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (previously filed).

CUSIP No. 01625V104

SCHEDULE 13G

Page 19 of 22

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated as of February 13, 2023

GENERAL ATLANTIC, L.P.

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director

GENERAL ATLANTIC PARTNERS 95, L.P.

By:	GENERAL ATLANTIC GENPAR, L.P., its general partner

By:	GENERAL ATLANTIC, L.P., its general partner

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director


GAPCO GmbH & CO. KG

By:	GAPCO MANAGEMENT GmbH., its general partner

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director

CUSIP No. 01625V104

SCHEDULE 13G

Page 20 of 22

GAP COINVESTMENTS III, LLC

By:	GENERAL ATLANTIC, L.P., its managing member

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director

GAP COINVESTMENTS IV, LLC

By:	GENERAL ATLANTIC, L.P., its managing member

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director


GAP COINVESTMENTS V, LLC

By:	GENERAL ATLANTIC, L.P., its managing member

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director


GAP COINVESTMENTS CDA, L.P.

By:	GENERAL ATLANTIC, L.P., its general partner

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director

CUSIP No. 01625V104

SCHEDULE 13G

Page 21 of 22

GENERAL ATLANTIC (SPV) GP, LLC

By:	GENERAL ATLANTIC, L.P., its sole member

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director


GAPCO MANAGEMENT GmbH.

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director

GENERAL ATLANTIC GENPAR, L.P.

By:	GENERAL ATLANTIC, L.P., its general partner

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director

CUSIP No. 01625V104

SCHEDULE 13G

Page 22 of 22

GENERAL ATLANTIC (ALN HLTH), L.P.

By:	GENERAL ATLANTIC (SPV) GP, LLC, its general partner

By:	GENERAL ATLANTIC, L.P., its sole member

By:	/s/ Michael Gosk
	Name:	Michael Gosk
	Title:	Managing Director

SCHEDULE A

Members of the GA Management Committee (as of the date hereof)

Name	Address	Citizenship
William E. Ford (Chief Executive Officer)	55 East 52nd Street 33rd Floor New York, New York 10055	United States
Gabriel Caillaux	23 Savile Row London W1S 2ET United Kingdom	France
Andrew Crawford	55 East 52nd Street 33rd Floor New York, New York 10055	United States
Martín Escobari	55 East 52nd Street 33rd Floor New York, New York 10055	Bolivia and Brazil
Anton J. Levy	55 East 52nd Street 33rd Floor New York, New York 10055	United States
Sandeep Naik	Asia Square Tower 1 8 Marina View, #41-04 Singapore 018960	United States
Graves Tompkins	55 East 52nd Street 33rd Floor New York, New York 10055	United States
N. Robbert Vorhoff	55 East 52nd Street 33rd Floor New York, New York 10055	United States
Eric Zhang	Suite 5704-5706, 57F Two IFC, 8 Finance Street Central, Hong Kong, China	Hong Kong SAR

Get the next $ALHC alert in real time by email

Date	Price Target	Rating	Analyst
12/3/2024	$13.00 → $17.00	Equal-Weight → Overweight	Stephens
10/11/2024		Sector Weight	KeyBanc Capital Markets
5/30/2024	$10.00	Outperform	Robert W. Baird
5/30/2024	$7.75 → $11.00	Neutral → Buy	BofA Securities
5/8/2024	$6.00 → $8.00	Neutral → Overweight	Piper Sandler
3/6/2024	$4.50	Underweight	Barclays
3/6/2024	$12.00 → $6.00	Overweight → Neutral	Piper Sandler
1/24/2024	$11.00	Buy	Stifel

SEC Form SC 13G/A filed by Alignment Healthcare Inc. (Amendment)

Chat with this insight

Recent Analyst Ratings for
$ALHC

$ALHC
Press Releases

Fastest customizable press release news feed in the world

Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition

Alignment Healthcare to Present at the BofA Securities Healthcare Conference

Alignment Healthcare Strengthens Leadership to Scale its AI-Enabled Medicare Advantage Platform with Two Key Appointments

$ALHC
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Alignment Healthcare upgraded by Stephens with a new price target

KeyBanc Capital Markets initiated coverage on Alignment Healthcare

Robert W. Baird initiated coverage on Alignment Healthcare with a new price target

$ALHC
Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

$ALHC
SEC Filings

SEC Form 144 filed by Alignment Healthcare Inc.

SEC Form 10-Q filed by Alignment Healthcare Inc.

Alignment Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$ALHC
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Mccarthy Margaret M was granted 1,290 shares, increasing direct ownership by 1% to 130,168 units (SEC Form 4)

Director Konowiecki Joseph S was granted 12,903 shares, increasing direct ownership by 1% to 1,177,049 units (SEC Form 4)

Amendment: Director Konowiecki Joseph S was granted 17,000 shares, increasing direct ownership by 1% to 1,275,221 units (SEC Form 4)

$ALHC
Financials

Live finance-specific insights

$ALHC
Leadership Updates

Live Leadership Updates

$ALHC
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition

Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025

Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance

Alignment Healthcare Appoints Sebastian Burzacchi to New Role of Chief Operating Officer of Management Services Organization and Andreas Wagner to Chief People Officer

Alignment Health Welcomes New Chief People Officer as It Scales to Serve More Seniors Nationwide

Alignment Health Appoints 3 New Executives to Further Drive Strategic Growth Nationally

Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

SEC Form SC 13G/A filed by Alignment Healthcare Inc. (Amendment)

Chat with this insight

Recent Analyst Ratings for $ALHC

$ALHC Press Releases

Fastest customizable press release news feed in the world

Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition

Alignment Healthcare to Present at the BofA Securities Healthcare Conference

Alignment Healthcare Strengthens Leadership to Scale its AI-Enabled Medicare Advantage Platform with Two Key Appointments

$ALHC Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Alignment Healthcare upgraded by Stephens with a new price target

KeyBanc Capital Markets initiated coverage on Alignment Healthcare

Robert W. Baird initiated coverage on Alignment Healthcare with a new price target

$ALHC Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

$ALHC SEC Filings

SEC Form 144 filed by Alignment Healthcare Inc.

SEC Form 10-Q filed by Alignment Healthcare Inc.

Alignment Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$ALHC Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Mccarthy Margaret M was granted 1,290 shares, increasing direct ownership by 1% to 130,168 units (SEC Form 4)

Director Konowiecki Joseph S was granted 12,903 shares, increasing direct ownership by 1% to 1,177,049 units (SEC Form 4)

Amendment: Director Konowiecki Joseph S was granted 17,000 shares, increasing direct ownership by 1% to 1,275,221 units (SEC Form 4)

$ALHC Financials

Live finance-specific insights

$ALHC Leadership Updates

Live Leadership Updates

$ALHC Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition

Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025

Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance

Alignment Healthcare Appoints Sebastian Burzacchi to New Role of Chief Operating Officer of Management Services Organization and Andreas Wagner to Chief People Officer

Alignment Health Welcomes New Chief People Officer as It Scales to Serve More Seniors Nationwide

Alignment Health Appoints 3 New Executives to Further Drive Strategic Growth Nationally

Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

Recent Analyst Ratings for
$ALHC

$ALHC
Press Releases

$ALHC
Analyst Ratings

$ALHC
Large Ownership Changes

$ALHC
SEC Filings

$ALHC
Insider Trading

$ALHC
Financials

$ALHC
Leadership Updates

$ALHC
Insider Purchases